Accelerating Growth in Medtech: the Next Surge in Portfolio Moves
Large medtech companies are struggling with growth challenges and stagnant valuations. Could M&A and divestitures reset the trajectory?
Read MoreLarge medtech companies are struggling with growth challenges and stagnant valuations. Could M&A and divestitures reset the trajectory?
Read MoreIndustry leaders in medtech experienced significant market transformation during 2021, precipitated by events related to ongoing structural changes within healthcare, the evolution and juxtaposition of various technological innovations,
Read Moredirectly engaging with referring physicians in an office-based setting is out of most medtech companies’ comfort zones, and significant effort is often required to convince a fragmented and dispersed audience of healthcare professionals to adopt a new therapy
Read MoreThe survey paints a picture of hospitals in the region that are getting back to normal operations – and resuming expansion – after two years of pandemic disruption.
Read MoreTo leverage the digital opportunity fully and create transformative change, health care innovators must address needs across the patient journey.
Read MoreTo rise to the occasion, leading companies are leveraging technology-driven supply chain models (AI, cloud and IoT enabled) with end-to-end digitized and transformed processes that leverage data and analytics at scale
Read Morevolume-based procurement aims to lower the price of medical consumables by tendering the market volume of cities, provinces or the country to manufacturers with the lowest price
Read MoreRecord-high valuations are forcing acquirers to get creative
Read Moreconnected medical devices do offer numerous benefits, including the opportunity for direct patient engagement and bringing the patient into closer interaction with caregivers in a way that is most compatible with their lifestyle
Read MoreMindray, GE Healthcare and Philips are strong performers
Read More